- Article
Apolipoprotein B and Glycemic Dysregulation: New Predictors of Type 2 Diabetes in High-Cardiovascular-Risk Populations
- Makhabbat Bekbossynova,
- Tatyana Ivanova-Razumova,
- Aknur Kali,
- Aliya Sailybayeva,
- Sadyk Khamitov,
- Gulnur Daniyarova,
- Kamila Akzholova and
- Timur Saliev
Background: Apolipoprotein B (ApoB), a key component of atherogenic lipoproteins, has been increasingly implicated in cardiometabolic disorders beyond dyslipidemia. However, its role in glycemic dysregulation remains unclear. This study aimed to inve...